- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05191654
Investigation of Cardiopulmonary Parameters, Motor Development and Muscle Strength in DS With and Without CHD
Investigation of Cardiopulmonary Parameters, Motor Development and Muscle Strength in Children With Down Syndrome With and Without Congenital Heart Disease
Study Overview
Status
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey
- Atılım University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosed with Down syndrome as a result of genetic analysis,
- For the congenital heart disease group; undergoing cardiac surgery at least 6 months before the evaluation, diagnosed as CHD by a pediatric cardiologist based on echocardiographic findings,
- For the group without congenital heart disease, patients who have not undergone cardiac surgery, are asymptomatic with a septal defect smaller than 4-5 mm, are expected to close, and are hemodynamically normal by a pediatric cardiologist,
- Children whose families were informed about the study and gave written consent to participate in the study were included in the study.
Exclusion Criteria:
- Having another genetic abnormality other than Down syndrome,
- undergoing surgery other than cardiac surgery,
- Having an orthopedic or neurological problem,
- Respiratory support,
- With atlantoaxial instability,
- Children with hematological disease were not included in the study.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
with Congenital heart diseases
|
Gross motor development was evaluated with Gross Motor Function Measure (GMFM-88).
Hand grip strength was measured with the Baseline Pneumatic Bulb Dynamometer.
Cardiopulmonary parameters values was evaluated with echocardiography.
|
|
without Congenital heart diseases
|
Gross motor development was evaluated with Gross Motor Function Measure (GMFM-88).
Hand grip strength was measured with the Baseline Pneumatic Bulb Dynamometer.
Cardiopulmonary parameters values was evaluated with echocardiography.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gross Motor Function Measure-88
Time Frame: october 2020- june 2021
|
Gross motor development of the participants was evaluated with the Gross Motor Function Measure-88 questionnaire. The value as a percentage was obtained as a result of the survey. Gross Motor Function Measure-88 consists of 5 sections that include the evaluation of Lying & Rolling, Sitting, Crawling & Kneeling, Standing, Walking, Running & Jumping activities. Each item in the sections consists of a 4-point scale. Scores for each section are summed and divided by 5.The maximum score on the scale is 100. A high score indicates good gross motor development. 0 = does not initiate
|
october 2020- june 2021
|
|
Bulb Dynamometer
Time Frame: october 2020- june 2021
|
Hand grip strength was measured with a Baseline Pneumatic Bulb Dynamometer (Fabrication Enterprises INC, Elmsford, NY USA).
With a bulb dynamometer, the spherical grip force is measured using a rubber balloon tip.
The bulb dynamometer has 3 removable sizes.
The values measured on the manometer are recorded in kPa.
The measurement is repeated 3 times and the highest value is taken.
|
october 2020- june 2021
|
|
Left ventricular ejection fraction (EF)
Time Frame: october 2020- june 2021
|
Echocardiographic findings performed in the last 6 months were evaluated by a pediatric cardiologist.
It is obtained by dividing the difference in left ventricular volume at end-diastolic and end-systolic by the end-diastolic left ventricular volume.
Left ventricular ejection fraction (EF) indicate the systolic function of the left ventricle.
Ejection fraction value show as a percentage (%).
The ejection fraction normal value is between 50 percent and 70 percent.
|
october 2020- june 2021
|
|
Interventricular septum wall thickness (IVS)
Time Frame: october 2020- june 2021
|
Echocardiographic findings performed in the last 6 months were evaluated by a pediatric cardiologist.
It is important in the risk classification potential of left ventricular systolic function.
Its value is show as millimeters (mm).
|
october 2020- june 2021
|
|
Left ventricular end-diastolic diameter (LVDd)
Time Frame: october 2020- june 2021
|
Echocardiographic findings performed in the last 6 months were evaluated by a pediatric cardiologist.
It is important in the risk classification potential of left ventricular systolic function.
Its value is show as millimeters (mm).
|
october 2020- june 2021
|
|
Fractional shortening (FS)
Time Frame: october 2020- june 2021
|
Echocardiographic findings performed in the last 6 months were evaluated by a pediatric cardiologist.
Fractional shortening evaluates left ventricular systolic function.
Fractional shortening value show as a percentage (%).
The value of normal fractional shortening in children is between 28-44%.
|
october 2020- june 2021
|
|
Wang Respiratory Score
Time Frame: october 2020- june 2021
|
The Wang respiratory score assesses respiratory frequency, wheezing, retraction, and general condition.
parameters are scored between 0-3 and summed.
A higher score indicates that the situation is getting severe.
|
october 2020- june 2021
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Heart Diseases
- Cardiovascular Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Disease
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Intellectual Disability
- Cardiovascular Abnormalities
- Abnormalities, Multiple
- Chromosome Disorders
- Syndrome
- Down Syndrome
- Heart Defects, Congenital
Other Study ID Numbers
- 59394181-604.01.01-75
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Down Syndrome
-
Rachel G. Greenberg, MD, MB, MHSEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsTerminatedHyperactivity in Children With Down Syndrome | Impulsivity in Children With Down SyndromeUnited States
-
Izgi Miray DemirbagRecruitingDown Syndrome (DS)Turkey (Türkiye)
-
Brigham and Women's HospitalNational Institutes of Health (NIH)Not yet recruitingDown Syndrome (DS)United States
-
Universidad de BurgosEuropean University Miguel de CervantesRecruiting
-
Aelis FarmaHospital del Mar Research Institute (IMIM)Enrolling by invitation
-
Sohag UniversityActive, not recruitingDown Syndrome | Cervical Spine Instability in Down SyndromeEgypt
-
Riphah International UniversityCompletedDown S SyndromePakistan
-
Hoffmann-La RocheCompletedHealthy Volunteer, Down SyndromeUnited Kingdom
-
Cairo UniversityCompleted
-
Institute of Child HealthCompleted
Clinical Trials on evaluation of cardiopulmonary parameters, gross motor development and hand grip strength
-
St. Jude Children's Research HospitalCompletedAcute Lymphoblastic LeukemiaUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Stichting StofwisselkrachtRecruitingLong-chain Fatty Acid Oxidation DisordersNetherlands
-
Atılım UniversityCompletedCOVID-19 | Sport Performance, Professional Overhead AthletesTurkey
-
Jonsson Comprehensive Cancer CenterCompleted
-
Xili WenCompletedSevere Intellectual DisabilityChina
-
St. Jude Children's Research HospitalTerminatedYoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or LeukemiaLeukemia | Hodgkin Lymphoma | Lymphoma, Non-Hodgkin'sUnited States
-
General University Hospital, PragueCompleted
-
Hacettepe UniversityCompleted
-
Izmir Bakircay UniversityCompletedBreast Cancer | Breast Cancer Female | Breast Cancer Lymphedema | Pain, Shoulder | Breast Carcinoma in Situ | Hand GraspTurkey
-
National Taiwan University HospitalCompleted